Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Dr. Reddy's Laboratories Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	500124
ISIN Demat	INE089A01031
Book Value	345.76

NSE Code	DRREDDY
Dividend Yield %	0.60
Market Cap	1119048.97

P/E	20.92
EPS	64.10
Face Value	1


	BSE		NSE

25-Jun-2025

Last Price	1340.85
Net Change	3.5
% Change	0.26%
Prev.Close	1337.35
Open	1317.60
High	1349.20
Low	1317.60
Volume	18234

Last Price	1341.60
Net Change	4.3
% Change	0.32%
Prev.Close	1337.30
Open	1348.30
High	1348.30
Low	1336.00
Volume	833145

Value	24443690
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1349.20
52-Week High	1420.20
52-Week Low	1025.90

Value	1116623853.8
Best Buy	0.00
Best Sell	1341.60
Best Quantity	0
Sell Quantity	230
Today's Range	1348.30
52-Week High	1421.49
52-Week Low	1020.00

Open Price	1342.20
High Price	1344.40
Low Price	1335.40
Last Price	1341.20
Prev Close	1334.70
Change	6.50
% Change	0.49 %

Average Price	1340.29
Underlying Value	1341.60
Number of contracts traded	5789
Turnover in Rs. Lakhs	48493
Open Interest	3451875.00
Change in O I	-1737500.00
% Change in O I	-33.48 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	230
Price	1341.60

Best Bid

Best Offer

Quantity	7500
Price	1339

Quantity	625
Price	1339.6

Holding Details

Latest Corporate Events

Bonus

1 : 1

28-Aug-06

Book Closure

17-Jul-24

19-Jul-24

Dividend

800 %

10-Jul-25

Company News

05-06-2025

Dr. Reddy's Laboratories,...

05-06-2025

Dr. Reddy’s Laboratories...

05-06-2025

Dr. Reddy's Laboratories ...

26-05-2025

USFDA completes GMP inspe...

17-05-2025

USFDA completes GMP inspe...

17-05-2025

Dr Reddys Laboratories in...

10-05-2025

Dr Reddys Laboratories in...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.